Guideline for cardiopulmonary and metabolic rehabilitation: Practical aspects and responsibilities;Diretriz de reabilitação cardiopulmonar e metabólica: Aspectos práticos e responsabilidades

Arquivos Brasileiros de Cardiologia

Volumn 86, Issue 1, 2006, Pages 74-82

  Cortez, Alberto Aguillar ^a   Ferraz, Almir ^a   Lucas Da Nóbrega, Antonio Cláudio ^a   Brunetto, Antonio Fernando ^a   Herdy, Artur Haddad ^a   Cordeiro Hossri, Carlos Alberto ^a   Neder, Carlos Alberto ^a   Negrão, Carlos Eduardo ^a   Soares Araújo, Cláudio Gil ^a   De Brito, Fábio Sândoli ^a   Drummond, Félix Albuquerque ^a   Roselino, Fernando ^a   Nogueira, Geraldo Ângelo ^a   Kikuchi Umeda, Iracema Ioco ^a   Oliveira Filho, Japy Angelini ^a   Caldas Teixeira, José Antonio ^a   Lazzoli, José Kawazoe ^a   Mastrocolla, Luiz Eduardo ^a   Benetti, Magnus ^a   Leitão, Marcelo Bichels ^a   Zager, Marcelo ^a   Nunes Alves, Maria Janieire Nazaré ^a   Grinberg, Max ^a   Godoy, Miltom ^a   Barbosa E Silva, Odwaldo ^a   Stein, Ricardo ^a   Costa, Ricardo Vivacqua ^a   Meneghelo, Romeu Sergio ^a   Moraes, Ruy Silveira ^a   Serra, Salvador Manoel ^a   Ramos, Salvador ^a   Guimarães, Jorge Ilha ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; ECONOMIC ASPECT; EVIDENCE BASED MEDICINE; HEART FAILURE; HUMAN; HYPERTENSION; LUNG DISEASE; MEDICAL CARE; MEDICAL EDUCATION; MEDICAL PRACTICE; PRACTICE GUIDELINE; REVIEW;

EID: 33644550662     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/s0066-782x2006000100011     Document Type: Review

References (52)

1. Araújo CGS, Carvalho T, Castro CLB, Vivacqua RC, Moraes RS, Oliveira Filho JA. Normatização dos Equipamentos e Técnicas da Reabilitação Cardiovascular Supervisionada. Arq Bras Cardiol 2004; 83(5): 448-52.
2. Moraes RS, Nóbrega ACL, Castro RRT, Negrão CE, Stein R, Serra SM, et al. Diretriz de Reabilitação Cardíaca. Arq Bras Cardiol 2005; 84: 431-40.
3. Rehabilitation After Cardiovascular Diseases, with Special Emphasis on Developing Countries. Report of a WHO Expert Committee, 1993.
4. Goble A, Worcester M. Best practice guidelines for cardiac rehabilitation and secondary prevention 1999, Department of Human Services: Victoria, Australia.
5. Godoy M et al. I Consenso Nacional de Reabilitação Cardiovascular. Arq Bras Cardiol 1997; 69(4): 267-91.
6. Ornish D et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998; 16;280(23):2001-7.
7. Niebauer J, Hambrecht R, Velich T, et al. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. Circulation. 1997; 96(8): 2534-41.
8. Jolliffe JA, Rees K, Taylor RS, Thompson D, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease [Cochrane Review]. Cochrane Database Syst Rev 2001;1: CD001800.
9. Ades PA, Pashkow FJ, Nestor JR. Cost-effectiveness of cardiac rehabilitation after myocardial infarction. J Cardiopulm Rehabil 1997; 17(4): 222-31.
10. Oldridge N et al. Number needed to treat in cardiac rehabilitation. J Cardiopulm Rehabil 2002; 22(1): 22-30.
11. Taylor RS et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004 15;116(10):682-92.
12. Hambrecht R et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation. 2004; 109(11):1371-8.
13. Belardinelli R et al. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 1999; 99(9): 1173-82.
14. Georgiou D. Cost-effectiveness analysis of long-term moderate exercise training in chronic heart failure. Am J Cardiol 2001 15;87(8):984-8.
15. Piepoli MF, Davos C, Francis DP, Coats AJ. ExTraMATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). Br Med J 2004; 328(7433):189.
16. Seamus P. Whelton, Ashley Chin, Xue Xin, Jiang He. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials.Ann Intern Med. 2002;136(7):493-503.
17. Perkins JM, Collin J, Creasy TS, Fletcher EW, Morris PJ. Exercise training versus angioplasty for stable claudication: long and medium term results of a prospective, randomized trial. Eur J Vasc Endovasc Surg 1996; 11:409-413.
18. Womack CJ, Ivey FM, Gardner AW, Macko RF. Fibrinolytic response to acute exercise in patients with peripheral arterial disease. Med Sci Sports Exerc 2000; 33(2): 214-9.
19. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 1990; 81(2): 602-9.
20. Verschuren WM, Jacobs DR, Bloemberg DPM, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Coutries Study. JAMA. 1995. 274: 131-6.
21. Ross R, Janssen I, Dawson J, et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res. 2004; 12(5): 789-98.
22. Watts K, Beye P, Siafarikas A, et al. Effects of exercise training on vascular function in obese children. J Pediatr. 2004; 144(5): 620-5.
23. Miyatake N, Takanami S, Kawasaki Y, Fujii M. Relationship between visceral fat accumulation and physical fitness in Japanese women. Diabetes Res Clin Pract. 2004; 64(3):173-9.
24. Franks PW, Ekelund U, Brage S, Wong MY, Wareham NJ. Does the association of habitual physical activity with the metabolic syndrome differ by level of cardio respiratory fitness? Diabetes Care. 2004; 27(5):1187-93.
25. Woo KS, Chook P, Yu CW, et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation. 2004; 27;109(16):1981-6.
26. Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weightloss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001;74(5):579-84.
27. Katzmarzyk PT, Church TS, Blair SN. Cardiorrespiratory Fitness Attenuates the Effects of the Metabolic Syndrome on All-Cause and Cardiovascular Disease Mortality in Men. Arch Intern Med 2004; 164:1092-97.
28. Herman WH, Hoerger TJ, Brandle M, et al. Diabetes Prevention Program Research Group.The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005 Mar 1;142(5):323-32.
29. Salman GF, Mosier MC, Beasley BW, Calkins DR. Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials. J Gen Intern Med 2003; 18(3): 213-21.
30. Griffiths TL, Burr ML, Campbell IA et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000;355:362-8.
31. Goldstein RS, Gort EH, Guyatt GH et al. Economic analysis of respiratory rehabilitation. Chest 1997;112:370-9.
32. Griffiths TL, Phillips CJ, Davies S, Burr ML, Campbell IA. Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax 2001;56;779-84.
33. Golmohammadi K, Jacobs P, Sin DD. Economic evaluation of a community-based pulmonary rehabilitation program for chronic obstructive pulmonary disease. Lung 2004; 182(3): 187-96.
34. Chapman RH, Stone PW, Sandberg EA, Bell C, Neumann PJ. A comprehensive league table of cost-utility ratios and a sub-table of "panel- worthy"studies. Med Decis Making 2000; 20(4):451-67.
35. O'Brien BJ. Chapter 3. Cost effectiveness of ICD therapy: a review of published evidence. Can J Cardiol 2000;16(10):1307-12.
36. Wilson TM , Tanaka H. Meta-analysis of the age-associated decline in maximal aerobic capacity in men: relation to training status. Am J Physiol Heart Circ Physiol 2000;278(3):H829-34.
37. Garrett NA, Brasure M, Schmitz KH, Schultz MM, Huber MR. Physical inactivity: direct cost to a health plan. Am J Prev Med. 2004;27(4):304-9.
38. Sakkas GK, Sargeant AJ, Mercer TH, et al. Changes in muscle morphology in dialysis patients after 6 months of aerobic exercise training Nephrol Dial Transplant 2003;18:1854-61.
39. Miller BW, Cress CL, Johnson ME, Nichols DH, Schnitzler MA. Exercise during hemodialysis decreases the use of antihypertensive medications. Am J Kidney Dis 2002; 39(4): 828-33.
40. Painter PL, Hector L, Ray K, et al. Effects of exercise training on coronary heart disease risk factors in renal transplant recipients. Am J Kidney Dis, 2003; 42(2):362-9.
41. Vaithilingam I, Polkinghorne KR, Atkins RC, Kerr PG. Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis, 2004; 43(1):85-9.
42. Stack AG, Molony DA, Rives T, Tyson J, Murthy BVR. Association of physical activity with mortality in the US dialysis population. Am J Kidney Dis. 2005; 45(4): 690-701.
43. Vongvanich P, Paul-Labrador MJ, Merz CN. Safety of medically supervised exercise in a cardiac rehabilitation center. Am J Cardiol 1996; 77:1383-5.
44. National Heart Foundation of New Zealand, Technical Report to Medical and Allied Professionals; Technical Report Number 78. 2002, National Heart Foundation: Auckland, NZ.
45. U.S. Department of Health and Human Services, Cardiac Rehabilitation Clinical Practice Guideline Number 17. Public Health Service, Agency for Health Care Policy and Research, National Heart, Lung and Blood Institute 1995; 17(PN# 96-0672).
46. Benzer W, Oldridge NB. Current concepts in cardiac rehabilitation. J Clin Basic Cardiol 2001; 4: 211-19.
47. Freemantle N et al. Beta Blockade after myocardial infarction: systematic review and meta regression analysis. Br Med J 1999;318(7200):1730-7.
48. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308(6921):81-106.
49. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344(8934):1383-9.
50. Kumana CR et al. Gauging the impact of statins using number needed to treat. JAMA 1999; 282(20):1899-901.
51. Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339(19):1349-57.
52. Grundy SM, Balady GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF, et al. Primary Prevention of Coronary Heart Disease: Guidance From Framingham: A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction. Circulation 1998; 97:1876-87.